On Tuesday, June 25, 2019 the National Comprehensive Cancer Network (NCCN) Oncology Policy Program hosted a summit focused on programatic approaches for assuring the highest quality of cancer care possible in the face of ever-changing laws and technology. The program took place at the National Press Club in Washington, D.C. and included a wide range of perspectives from clinicians to lawmakers, advocates to patients and others.
CCK’s Dr. Pavan Reddy attended and spoke on behalf of Kansas Society of Clinical Oncology, CCK and physicians alike. “Recent advances in cancer care have been driven by the identification of targetable mutations, harnessing the immune system’s ability to fight cancer, and improved symptom management, explained Dr. Reddy. “These advances were fueled by drug development and testing through clinical trials. It is essential to encourage patient participation in these trials, in order to deliver high quality and personalized cancer care while continuing to advance the science.”
You can read the full article, including statements by other attendees, here.
The NCCN is a not-for-profit alliance of leading cancer centers dedicated to developing resources that present valuable information to health care providers. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.
To learn more about NCCN, click here.
